Today's Rundown Johnson & Johnson sets stage for COVID-19 shot rollout with 'first in a series' manufacturing deal FDA warns that hyped COVID-19 drug hydroxychloroquine is too risky outside the hospital Oncology practices detail quick switch to telehealth, barriers to using technology permanently Sanofi gets COVID-19 sales boost as CEO touts vaccine manufacturing prowess Biopharma roundup: Gilead hoping to read out new remdesivir data early Healthcare roundup: Trump signs package with more funding for hospitals; Massachusetts, Doctor on Demand offer free telehealth to uninsured China's Sinovac amps up COVID-19 vaccine work with new facility backed by Chinese government Here's how much outpatient visits have plummeted amid COVID-19 pandemic, Harvard analysis shows Alphabet's Verily rolls out COVID screening tool for health systems Avalere: One-third of physician services now eligible for telehealth reimbursement Coronavirus crisis opens access to online opioid addiction treatment Featured Story | | | Friday, April 24, 2020 Johnson & Johnson has joined a suite of drugmakers hoping to pump out a COVID-19 vaccine as fast as possible. Now, it's pairing with contract manufacturer Emergent BioSolutions to gear up for its potential vaccine launch. |
|
|---|
|
Top Stories Friday, April 24, 2020 After President Donald Trump touted the malaria drug hydroxychloroquine as a potential COVID-19 “game-changer," the FDA authorized it for emergency use. But now the drug regulator is warning about serious side effects. Thursday, April 23, 2020 Oncology practices have reported great success quickly transitioning to telehealth, but questions on requirements for deploying the technology and reimbursement remain. Friday, April 24, 2020 Sanofi CEO Paul Hudson's not concerned about meeting an optimistic 18-month timeline for developing a COVID-19 vaccine. He's worried there won't be enough doses available. But he figures Sanofi and its partner GlaxoSmithKline have the world’s best chance at meeting demand. Friday, April 24, 2020 After taking its lumps in an inconclusive Chinese study in severe COVID-19 patients, Gilead Sciences is reportedly ready to read out results from a major study of investigational candidate remdesivir as soon as May. Friday, April 24, 2020 FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry. Friday, April 24, 2020 China-based biotech Sinovac, one of many drugmakers seeking a COVID-19 vaccine, is leveraging aid from its home country to help it cross the finish line. But first, Sinovac will have to build out a massive new facility on the government's dime. Thursday, April 23, 2020 The COVID-19 pandemic has led the number of outpatient procedures to plummet, a new report shows. Friday, April 24, 2020 Verily has rolled out a COVID-19 screening tool for health systems and hospitals to help automate frontline response to the health crisis. Alphabet's life sciences research arm and a sister company to Google, Verily joins a growing list of technology companies to develop COVID screening chatbots that can be embedded into hospitals' websites. Thursday, April 23, 2020 About one-third of physician service payments are now eligible for reimbursement via telehealth based on existing and temporary federal payment policies. An analysis by Avalere Health looks at the impact of COVID-19 telehealth policies by specialty. Friday, April 24, 2020 Opioid addiction isn’t taking a break during the coronavirus pandemic. But the U.S. response to the viral crisis is making addiction treatment easier to get. |
